Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

242 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Monoclonal antibodies which block cellular receptors of poliovirus.
Minor PD, Pipkin PA, Hockley D, Schild GC, Almond JW. Minor PD, et al. Virus Res. 1984;1(3):203-12. doi: 10.1016/0168-1702(84)90039-x. Virus Res. 1984. PMID: 6099657
Monoclonal antibodies specific for the Sabin vaccine strain of poliovirus 3.
Ferguson M, Yi-hua Q, Minor PD, Magrath DI, Spitz M, Schild GC. Ferguson M, et al. Among authors: minor pd. Lancet. 1982 Jul 17;2(8290):122-4. doi: 10.1016/s0140-6736(82)91091-1. Lancet. 1982. PMID: 6123838
Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M, Minor PD, Magrath DI, Schild GC. Ferguson M, et al. Among authors: minor pd. Dev Biol Stand. 1984;57:151-5. Dev Biol Stand. 1984. PMID: 6098495
An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies.
Evans DJ, McKeating J, Meredith JM, Burke KL, Katrak K, John A, Ferguson M, Minor PD, Weiss RA, Almond JW. Evans DJ, et al. Among authors: minor pd. Nature. 1989 Jun 1;339(6223):385-8, 340. doi: 10.1038/339385a0. Nature. 1989. PMID: 2542797
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M. Cutrone R, et al. Among authors: minor p. Cancer Res. 2005 Nov 15;65(22):10273-9. doi: 10.1158/0008-5472.CAN-05-2028. Cancer Res. 2005. PMID: 16288015
Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.
Barrett AD, Pryde A, Medlen AR, Ledger TN, Whitby JE, Gibson CA, DeSilva M, Groves DJ, Langley DJ, Minor PD. Barrett AD, et al. Among authors: minor pd. Vaccine. 1989 Aug;7(4):333-6. doi: 10.1016/0264-410x(89)90196-5. Vaccine. 1989. PMID: 2479185
New poliovirus vaccines: a molecular approach.
Almond JW, Stanway G, Cann AJ, Westrop GD, Evans DM, Ferguson M, Minor PD, Spitz M, Schild GC. Almond JW, et al. Among authors: minor pd. Vaccine. 1984 Sep;2(3):177-84. doi: 10.1016/0264-410x(84)90081-1. Vaccine. 1984. PMID: 6085198 Review.
Emerging/disappearing viruses future issues concerning polio eradication.
Minor P. Minor P. Virus Res. 2002 Jan 30;82(1-2):33-7. doi: 10.1016/s0168-1702(01)00384-7. Virus Res. 2002. PMID: 11885947 Review. No abstract available.
Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man.
MacLennan C, Dunn G, Huissoon AP, Kumararatne DS, Martin J, O'Leary P, Thompson RA, Osman H, Wood P, Minor P, Wood DJ, Pillay D. MacLennan C, et al. Among authors: minor p. Lancet. 2004 May 8;363(9420):1509-13. doi: 10.1016/S0140-6736(04)16150-3. Lancet. 2004. PMID: 15135598
False-positive immunoblot results with antibodies against human immunodeficiency virus.
Thorpe R, Bird C, Garrett AJ, Minor PD, Schild GC, Thomas DP. Thorpe R, et al. Among authors: minor pd. Lancet. 1986 Sep 13;2(8507):627-8. doi: 10.1016/s0140-6736(86)92449-9. Lancet. 1986. PMID: 2875338 No abstract available.
242 results
Jump to page
Feedback